Clinical Study

A Randomized Phase III Study Of Sublobar Resection (Sr) Versus Stereotactic Ablative Radiotherapy (Sabr) In High Risk Patients With Stage I Non-Small Cell Lung Cancer (Nsclc)

Posted Date: Dec 15, 2016

  • Investigator: Sandra Starnes
  • Co-Investigator: Sarah Elizabeth Figueira
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this study is to compare the results of two standard treatments. The two treatments include sublobar resection and radiation. Sublobar resection is the removal of a small portion of a lung. Radiation, orstereotactic ablative radiotherapy, i


To Be Eligible To Participate In This Study, Participants Must Have Lung Cancer, Or A Lung Nodule Suspicious For Lung Cancer Which May Be Removable With Surgery. Typically This Is Done By Removing A Lobe Of The Lung. Due To Certain Risks, You Would Requir


Phase Iii, Stu-022015-069, Lung, Non-Small Cell Lung Cancer, Cancer

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.